MEI Pharma Revenue, Profits - MEIP Quarterly Income Statement

Add to My Stocks
$4.61 $0.04 (0.88%) MEIP stock closing price Sep 17, 2018 (Closing)

Stock analysis based on fundamentals means looking at financial statements in addition to the MEI Pharma stock price. In the income statement, an investor can check for important parameters like the topline or sales, the bottomline or profits, the basic EPS, dividends etc. Like any other income statement, the MEIP income statement also itemizes revenue/sales, operating expenses, and profits/bottomline for a quarter or year and reflects a QoQ revenue decline of 0 when compared to the same period in the past. Along with MEI Pharma assets and MEI Pharma free cash flow, MEI Pharma profits as shown in profit and loss statement give key insights about the business. The net profit for 2018 Q4 is $-19.25M and the 2018 Q4 revenue is $-.

View and download details of revenue and profits for MEI Pharma for latest & last 40 quarters.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jul - Jun2018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q3
MEI Pharma Revenues or Net Sales
-----4.51M17.2M1.1M--
Cost Of Goods Sold (COGS)1.11M---1M1.14M1.77M1.09M--
MEI Pharma Gross Profit
-0.56M-0.49M-0.37M-0.33M-0.53M3.35M15.42M---
Research & Development Expense4.46M3.07M3.44M6.06M2.08M1.87M1.64M1.64M3.99M3.42M
Selling General & Admin Expense2.46M2.48M2.35M2.48M1.82M2.15M1.97M2.68M1.84M1.99M
Income Before Depreciation Depletion Amortization-7.47M-6.05M-6.17M-8.88M-4.45M-0.66M11.81M-4.32M-5.83M-5.41M
Depreciation Depletion Amortization----------
Non Operating Income----------
Interest Expense----------
MEI Pharma Pretax Income
-19.25M-5.94M-6.07M-8.78M-4.35M-0.6M11.88M-4.26M-5.78M-5.37M
Provision for Income Taxes----------
MinorityInterest----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations-19.25M-5.95M-6.08M-8.79M-4.34M-0.6M11.89M-4.27M-5.77M-5.37M
Extraordinary Items & Discontinued Operations----------
MEI Pharma Profit/ Loss (Net Income)
-19.25M-5.95M-6.08M-8.79M-4.34M-0.6M11.89M-4.27M-5.77M-5.37M
Average Shares used to compute Diluted EPS53.48M37.45M37.41M37.25M36.19M37.17M37.22M35.75M33.94M34.42M
Average Shares used to compute Basic EPS53.48M37.45M37.41M37.25M36.19M37.17M37.17M35.75M33.94M34.42M
Income Before Nonrecurring Items-7.18M-5.95M-6.08M-8.79M-4.34M-0.6M11.89M-4.27M-5.77M-5.37M
Income from Nonrecurring Items-12.07M---------
MEI Pharma Earnings Per Share Basic Net
-0.41-0.16-0.16-0.24-0.12-0.020.32-0.12-0.17-0.16
MEI Pharma Earnings Per Share Diluted Net
-0.41-0.16-0.16-0.24-0.12-0.020.32-0.12-0.17-0.16
EPS Diluted Before Nonrecurring Items-0.13-0.16-0.16-0.24-0.12-0.020.32-0.12-0.17-0.16
Preferred Dividends Acc Pd----------
Dividends Common0.000.000.00-------
Dividend Per Share Common0.000.000.000.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Before investing one should read a report on MEI Pharma stock analysis. It helps to look at the following income statement items:

  • Topline: A growing topline, as seen from the MEI Pharma revenue chart, as isn't the case with MEI Pharma indicates a sagging business. One needs to compare the QoQ topline or sales growth of MEIP stock with its peers like IPHYF stock and CNCE stock to see if the growth compares well with what can be expected from a company in that industry.
  • Bottom line: Most businesses like MEI Pharma try to grow their profits by growing their topline and by increasing their operating efficiency. A healthy bottom line growth implies a good investment.

The income statement is also called the profit and loss statement. Apart from the MEIP income statement, one can check the MEI Pharma historical stock prices to check how the price has moved with time.

MEI Pharma Income Statement - Key Financial Ratios

PS Ratio (price sales ratio)
152.19
Dividend Yield
0%